Dr. Lindsey Rae Goetz, MD

Dr. Goetz practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Dr. Goetz's NPI, 1356669865, was assigned on May 7, 2010. Dr. Goetz graduated from University of Colorado Anschutz Medical Campus in 2010. Dr. Goetz's Colorado license number on file is DR0052324.

Dr. Goetz's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Dr. Goetz's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Goetz to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goetz practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Goetz's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Goetz is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Goetz's licenses on file in 6 states: Colorado, California, Georgia, Montana, South Carolina and North Carolina.

Dmand AI lists acute kidney failure, chronic diabetes, chronic hypertension, chronic kidney disease and tobacco use among the conditions Dr. Goetz treats.

CMS data shows 956 Medicare services from Dr. Goetz across 17 procedure codes in 2024, for 278 Medicare patients. Medicare paid $69,492 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 278 Medicare patients who saw Dr. Goetz in 2024. The largest group is 65 to 74, with 118 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 59% are also on Medicaid. Their average risk score is 6.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goetz's median patient age at 62, with 41% women.

In 2024, Dr. Goetz wrote 73 Medicare Part D claims for 27 patients. 95% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $122 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Goetz for performance year 2024, reported as part of a group. Dr. Goetz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Goetz as offering telehealth.

Dmand AI links 3 papers to Dr. Goetz, published from 2016 to 2018. The most frequent topics are Acute Kidney Injury, Complement Activation and Complement Factor H. Dr. Goetz's most frequent co-authors are V Michael Holers, MD, Joshua M. Thurman, MD and Suzanne Leigh Katsanos, MD.

CMS Open Payments shows 8 general payments to Dr. Goetz from 5 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $246.

Dr. Goetz graduated from University of Colorado Anschutz Medical Campus in 2010.

Dr. Goetz is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.